About this event

  • Date and time Fri 3 Nov 2023 from 9:00am to 6:00pm
  • Location Royal Society of Medicine
  • Organised by Digital Health

Digital Twins are established in other industries but are only now being incorporated into healthcare. They refer to virtual representations or simulations of real-world medical entities, processes, or systems. These digital replicas are created by collecting and integrating various data sources, such as medical records, patient data, and sensor data to model and simulate healthcare-related elements using advanced technology like artificial intelligence (AI) and machine learning (ML).

Join this exciting and unique event that will provide an introduction to digital twins and their potential for improving both personalised medicine and healthcare provision. It will explore how interventions are being tailored to the individual, how clinical trials could be transformed, what building a virtual human involves the implications for prevention and sustainability in healthcare and the regulatory and ethical questions posed by such technology. This is a unique opportunity for the RSM to host an event with thought leadership and pioneers, and lead the way in sharing options and considering how to manage potential risks of digital twins healthcare. 

By attending this event, you will

  • Understand what digital twins could mean for clinical practice and pathways
  • Review the regulatory pathways e.g. FDA, MHRA, MDU and explore the ethical considerations
  • Examine where digital twins are in the research and provider landscape 
  • Learn from those involved in insilico trials 
  • Explore how digital twins could impact sustainability and healthcare accessibility for all sections of the population 
  • Hear a critique of the role of AI: explainability and limits, keeping it safe
  • Discuss the way ahead

Follow us on:



We would like to thank our sponsors BiteWorld, IBM and The Technology Partnership for their support of this meeting.


View the programme

Registration, tea and coffee
Welcome and introduction

Dr Julia Manning, President, Digital Health Council, Royal Society of Medicine

Virtual you: The medical revolution

Dr Roger Highfield, Science Director, Science Museum Group

Session 1: Tailoring interventions to the individual

Lessons from other industries

Dr Mark Davies, Chief Health Officer, IBM

Digital twins for pregnancy

Professor Michelle Oyen, Inaugural Director of the new Center for Women’s Health Engineering, Washington University, St Louis, USA

The role of synthetic data

Mr Matthew Whitty, Director of Commercial Partnerships, MDClone

Questions and answers
Tea and coffee break

Session 2: Accelerating clinical trials

Creating a digital biological twin for cancer patients

Professor Tony Ng, Head of School, School of Cancer and Pharmaceutical Sciences, King's College London and Vice President, Digital Biological Twin Unit, GSK

Digital twins in clinical trials

Dr Wahbi El-Bouri, Fellow, University of Liverpool

Cardiac digital twins for in silico trials

Dr Caroline Roney, Lecturer, Computational Medicine, Queen Mary University of London

Questions and answers
Building a virtual human

Professor Andrea Townsend-Nicholson, Professor, Biochemistry and Molecular Biology, University College London


Session 3: Patients, workflows and sustainability

Weclome back

Dr Azeem Alam, Council member, Digital Health Council, Royal Society of Medicine

Improving processes through comparisons and virtual trials

Mr Jacob Koris, GIRFT Innovation and Technology Lead, NHS England and NHS Improvement

Supercomputers and virtual humans: The next medical revolution

Dr Mariano Vazquez, Co-Founder and Chief Technology Officer, ELEM Biotech

Hacking patient enrolment using digital twins

Dr Ed Roberts, Chief Product Officer, Iceberg

Questions and answers

Session 4: Patients, safety, regulation and ethics

Digital twins and complexity

Dr Saira Ghafur, Lead for Digital Health, Institute of Global Health Innovation, Imperial College London

Can real-world patients really benefit?

Dr Sheuli Porkess, Chief Medical Officer and Business Unit Director, Precisia Life Sciences, a C2-AI business

How to build a human digital twin – Regulatory considerations

Mr Benedikt von Thüngen, Founder and Chief Executive Officer, Sanome

Questions and answers
Tea and coffee break
Welcome back

Dr Grace Hatton, Council Member, Digital Health Council, Royal Society of Medicine

Brick by brick: Reflections from the day using LEGO® SERIOUS PLAY® methodology

Dr Matt Dexter, User Experience Consultant, TTP

Digital twins - State of the art

Professor Peter Coveney, Associate Director, Advanced Research Computing Centre, University College London and Director, Centre for Computational Science, University College London

Closing remarks

Dr Julia Manning

Close of meeting

Followed by drinks reception



Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom


Registration for this event will close at 1:00am on Thursday 2 November 2023. Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.